bortezomib for injection poudre pour solution
juno pharmaceuticals corp. - bortézomib (bortézomib, ester boronique de mannitol) - poudre pour solution - 1mg - bortézomib (bortézomib, ester boronique de mannitol) 1mg - antineoplastic agents
bortezomib for injection poudre pour solution
juno pharmaceuticals corp. - bortézomib (bortézomib, ester boronique de mannitol) - poudre pour solution - 2.5mg - bortézomib (bortézomib, ester boronique de mannitol) 2.5mg - antineoplastic agents
menquadfi
sanofi pasteur - neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid - méningite méningococcique - vaccins - menquadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w, and y. the use of this vaccine should be in accordance with available official recommendations.
busulfan for injection solution
auro pharma inc - busulfan - solution - 60mg - busulfan 60mg - antineoplastic agents
truvelog mix 30
sanofi winthrop industrie - insuline asparte - diabète sucré - les médicaments utilisés dans le diabète - truvelog mix 30 is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 10 years and above.
ag-trazodone comprimé
angita pharma inc. - chlohydrate de trazodone - comprimé - 50mg - chlohydrate de trazodone 50mg
ag-trazodone comprimé
angita pharma inc. - chlohydrate de trazodone - comprimé - 100mg - chlohydrate de trazodone 100mg
ag-trazodone comprimé
angita pharma inc. - chlohydrate de trazodone - comprimé - 150mg - chlohydrate de trazodone 150mg
busulfan pour injection solution
eugia pharma inc. - busulfan - solution - 60mg - busulfan 60mg